Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
  • Ask Questions

Tag: drug targeting

January 11, 2021 CD as API / CD derivatives / Drug delivery / Pharma applications

Cyclolab and EpiPharma Form Joint Venture company Targetrin Therapeutics to Develop and Commercialize novel conjugated Cyclodextrin – Peptide drugs

Cyclolab, the oldest, world renowned cyclodextrin research, development and manufacturing company, and EpiPharma, a bio-pharmaceutical services and peptide drug development

Continue reading

December 23, 2019 Drug delivery / Pharma applications

Innovative Congress on Pharma and Pharmaceutical Sciences (ICPP -2020)

Innovative Congress on Pharma and Pharmaceutical Sciences (ICPP -2020) being organized during March 12-13, 2020 at Singapore City, Singapore. The

Continue reading

Recent Posts

  • BIO-Europe Spring® Digital
  • HPBCD is a unique component in Janssen’s COVID-19 vaccine candidate
  • Effect of buffers on the stability of SBECD complexes
  • Solution Density Models as Functions of Sodium Chloride, HPBCD, and temperature
  • New approach in ocular drug delivery: cyclodextrin-containing mucoadhesive eye drop formulations

Tags

antiviral Betadex Sulfobutyl Ether Sodium Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems Drugs FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease Polymer remdesivir SBECD Special issue Synthesis Trappsol

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (8)
  • Analysis (12)
  • CD as API (99)
  • CD derivatives (124)
  • Cosmetics and toilettry (10)
  • Drug delivery (191)
  • E-ducation (41)
  • Environmental (41)
  • Events (98)
  • Food (57)
  • Gene delivery (6)
  • In Hungarian (4)
  • Non-pharma applications (97)
  • Other industrial use (34)
  • Pharma applications (351)
  • Supramolecular systems (7)
  • Uncategorized (23)

Top Posts

  • HPBCD is a unique component in Janssen's COVID-19 vaccine candidate
  • World Biotechnology Industry Conference-2020 (WBC-2020)
  • Nature Protocols: Facile synthesis of per(6-O-tert-butyldimethylsilyl)-α-, β-, and γ-cyclodextrin
  • The use of β-CDs to improve honey bee health
  • Potential COVID-19 therapeutics from a rare disease: utilization of lipid dysregulation to combat viral infectivity
  • Cyclodextrins in soft drinks
  • Sedor Pharmaceuticals Receives FDA Approval for SESQUIENT™ (SBECD-enabled fosphenytoin)
  • Antiviral Viroblock masks modified by CD from Wacker
  • CycloLab at BIO Digital
  • Oculis aces the Phase 2 clinical trial for OCS-01 treating DME

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 289 other subscribers